Super fast-acting insulin compositions
US8568713B2 · kind B2 · utility
37Cited by
76References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 2012 |
| Grant date | Oct 29, 2013 |
| Priority date | — |
| Expiry date | May 18, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are methods for control of post-prandial glucose in diabetic subjects by administering a fast-acting insulin analog and a hyaluronidase degrading enzyme. The fast-acting insulin analog and a hyaluronidase are administered between 15 minutes before the meal and 30 minutes after commencing the meal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.